Microbiological study of ventilator-associated pneumonia (VAP) after implantation of pneumonia program zero (NZ)
نویسندگان
چکیده
Results 01.04.11/01.04.1215 VAP.Clinical diagnosis: support clinical radiological+new infiltrate 80%. Extension of previous infiltrate + clinical worsening (2nd pneumonia)20%Germ: A. baumanii 44.44%: resistance: amikacin, ampicilin, imipenem, tobramicin P. aeuroginosa 22.22%: resistance: amikacin, ceftacidim, ciprofloxacin, colistin, imipenem, levofloxacin, meropenem, piperacilinatazobactam (P-T) MRSA 16.67% Polymicrobial 26.67%. Inflammatory response: sepsis 33.33%, severe sepsis 33.33%. 01.04.12/01.04.13-6 VAPDiagn: support clinical radiological+new infiltrate 66.67% extension of previous infiltrate + clinical worsening (2nd pneumonia) 16.67%, CT 16.67%.Germ: S. Aureus 22 .22%: no resistance S. Maltophilla 22.22% no resistance Polymicrobial 50%. Without diagnostic 16.67% Inflammatory response: sepsis 50%, severe sepsis 33.33%, shock 16.67% 01.04.13/01.04.1410 VAPDiagn: support clinical radiological+new infiltrate 60% extension of previous infiltrate + clinical worsening (2nd pneumonia) 30%, CT 10%.Germ: S. Aureus 25% E. Coli 16.67%: resistance: ciprofloxacin, amox-clav. H. Influnzae 8.33% P. aeuroginosa 8.33%: resistance :cefepime, ceftacidime, imipenem, meropenem, P-T polimicrobial 20%. Inflammatory response: sepsis 50%, severe sepsis 30%, shock 20%. 01.04.14/01.04.153VAP Diagn: support clinical radiological+new infiltrate 68.57% extension of previous infiltrate + clinical worsening (2nd pneumonia) 22.86% CT 8.57%.Germ: Hospital Universitario San Cecilio, Unidad Cuidados Intensivos, Granada, Spain Fernández Fernández et al. Intensive Care Medicine Experimental 2015, 3(Suppl 1):A1021 http://www.icm-experimental.com/content/3/S1/A1021
منابع مشابه
Erratum to: Comparison of the evolution of mechanical ventilation associated pneumonia (VAP) before the implantation of selective digestive decontamination (DDS) and after implantation of pneumonia zero program (NZ)
Erratum to: Comparison of the evolution of mechanical ventilation associated pneumonia (VAP) before the implantation of selective digestive decontamination (DDS) and after implantation of pneumonia zero program (NZ) Reference 1. Fernández Fernández et al (2015) Comparison of the evolution of mechanical ventilation associated pneumonia (VAP) before the implantation of selective digestive deconta...
متن کاملعنوان: Impact of Care Program on Ventilator-Associated Pneumonia Incidence: A Clinical Trial
چکیده: Background: Ventilator-associated pneumonia (VAP) is one of the common problems in patients who are under mechanical ventilation and increases the hospitalization duration and treatment expenses. The current study was conducted to determine the impact of a care program on VAP. Methods: This clinical trial was performed on intubated patients who were under mechanical ventilation in Intens...
متن کاملDoes Re-intubation Increased Risk of Ventilator- Associated Pneumonia (VAP) in Pediatric Intensive Care Unit Patients?
Introduction:ventilator- associated pneumonia(VAP),as defined by the centers for disease control and prevention (CDC),is a pneumonia that occurs in a patient receiving mechanical ventilation that develops 48 hours or more after initiation of ventilation.re-intubation which occur within 72 hours of planned extubation may effect VAP incidence.the aim of this study was to determine VAP incidence i...
متن کاملThe prevalence of Mycoplasma pneumoniae infection in patients with ventilator-associated pneumonia hospitalized in intensive care unit
Background: Ventilator-associated pneumonia (VAP) is a type of hospital acquired pneumonia with the mortality rate between 27% and 76% that develops more than 48–72 h after endotracheal intubation. Possible causes leading to this infection can be Mycoplasma pneumoniae. The objective of this study was to determine the presence of Mycoplasma pneumoniae in bronchoalveolar samples of patients with ...
متن کامل[Should the diagnosis of ventilator associated pneumonia be improved?].
Ventilator associated pneumonia (VAP) is the leading nosocomial infection in intensive care. It is associated with increased ICU and hospital stay, an increased use of antibiotics, and greater hospital costs. The recently launched Pneumonia Zero project (NZ) undoubtedly constitutes a challenge for professionals in the ICU, and has been designed to reduce the high incidence rates described. It i...
متن کامل